小米-W(01810.HK)14系列手機首銷四小時打破四大電商平台近一年國產手機全天紀錄
小米-W(01810.HK)公布,旗下小米14系列手機於周二(10月31日)開賣以來,僅5分鐘首銷銷量已大增至上代小米13系列首銷總量的六倍。小米14單品首銷四小時的銷量及銷售額打破「天貓、京東-SW(09618.HK)、抖音、快手-W(01024.HK)」四大電商平台近一年所有國產手機首銷的全天紀錄,再次刷新銷售紀錄。
此外,截至周二(31日)晚上11時59分,小米全通路累計支付金額突破100億元人民幣,取得「開門紅」。
小米今日(11月2日)股價曾升5.8%高見15.04元。現報14.92元,升4.92%,成交7,747.64萬股,涉資11.52億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.